Your browser doesn't support javascript.
loading
[Chinese expert guidance on overall application of lenvatinib in hepatocellular carcinoma].
Yang, X R; Sun, H C; Xie, Q; Zhang, W G; Jia, W D; Zhao, M; Zhao, H T; Liu, X F; Zhou, L D; Yan, S; Xu, L; Wang, N Y; Ding, Y; Zhu, X D; Zhou, J; Fan, J.
  • Yang XR; Department of Liver Surgery, Research Institute of Liver Cancer, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Sun HC; Department of Liver Surgery, Research Institute of Liver Cancer, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Xie Q; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
  • Zhang WG; Hepatic Surgery Center,Tongji Hospital,Tonji Medical College, Huazhong University of Science and Technolog, Wuhan 430030, China.
  • Jia WD; Department of Liver Surgery, the First Affiliated Hospital of University of Science and Technology of China, Hefei 230001, China.
  • Zhao M; Department of Minimally Invasive and Interventional, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Guangzhou 510060, China.
  • Zhao HT; Department of Hepatic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Liu XF; Department of Oncology, Qinhuai Medical District, Eastern Theater General Hospital of PLA, Nanjing 210002, China.
  • Zhou LD; Department of Liver Surgery, Xiangya Hospital of Central South University, Changsha 410008, China.
  • Yan S; Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
  • Xu L; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Wang NY; Department of Cancer Center, the First Hospital of Jilin University, Changchun 130021, China.
  • Ding Y; Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
  • Zhu XD; Department of Liver Surgery, Research Institute of Liver Cancer, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhou J; Department of Liver Surgery, Research Institute of Liver Cancer, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Fan J; Department of Liver Surgery, Research Institute of Liver Cancer, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Gan Zang Bing Za Zhi ; 31(10): 1018-1029, 2023 Oct 20.
Article en Zh | MEDLINE | ID: mdl-38016765
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Límite: Humans País como asunto: Asia Idioma: Zh Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Límite: Humans País como asunto: Asia Idioma: Zh Año: 2023 Tipo del documento: Article